Search

Your search keyword '"Sanehito HARUYAMA"' showing total 72 results

Search Constraints

Start Over You searched for: Author "Sanehito HARUYAMA" Remove constraint Author: "Sanehito HARUYAMA" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
72 results on '"Sanehito HARUYAMA"'

Search Results

1. Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression

7. Subepidermal blistering disease acquired autoantibody against laminin 332 during treatment for bullous pemphigoid

8. Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma

9. Alopecia Areata-like Hair Loss Accompanying Toxic Epidermal Necrolysis

10. Annular erythematous eruption with a high response to mosquito bite

11. Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression

13. Drug Eruption Caused by Rosuvastatin

14. Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23

15. Maculopapular type drug eruption caused by pregabalin: A case and literature review

16. A high expression of cell adhesion molecule 1 (CADM1) is an unfavorable prognostic factor in mycosis fungoides

17. Excessive hair growth in a patient with psoriatic erythroderma following secukinumab administration

18. Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions

19. Calciphylaxis following acute renal injury: a case and literature review

20. Erythema papulosa semicircularis recidivans associated with primary pancreas B cell lymphoma

21. Dome-shaped metastatic lesion on the scalp from a uterine smooth muscle tumor of uncertain malignant potential (STUMP)

22. Lichenoid Drug Eruption Caused by Limaprost Alfadex

23. Anaphylactoid purpura triggered by cellulitis as a favorable prognosis: case report and literature review

24. A possible pathogenetic role of IL-23/IL-17 axis in rheumatoid nodules in patients with rheumatoid arthritis

25. Stevens-Johnson Syndrome After Influenza Vaccine Injection

26. Endometriosis in the setting of Muckle-Wells syndrome treated with an IL-1β antagonist

27. Drug eruption caused by memantine

28. Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment

29. Maculopapular eruption caused by doripenem

30. Acute edema/cutaneous distension syndrome due to POEMS syndrome

31. Lichenoid drug eruption caused by adalimumab: a case report and literature review

32. Drug eruption caused by secukinumab

34. Photoallergic Drug Eruption Caused by Certolizumab Pegol

35. Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23

37. Expression of activation induced deaminase (AID) and BRAF V600E mutation in malignant melanoma

38. Maculopapular type drug eruption caused by fosphenytoin

39. Fixed drug eruption-like macules caused by febuxostat

40. Multiple fixed drug eruption caused by ropinirole in a patient with Parkinson's disease

41. Maculopapular type drug eruption caused by silodosin

42. Acute edema/cutaneous distension syndrome representing as eczéma craquelé-like change: A case and published work review

43. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review

44. First case of acute generalized exanthematous pustulosis caused by pitavastatin: possible pathogenetic role of IL-36

46. 575 High expression of cell adhesion molecule 1 is a predictive unfavorable prognostic factor in patients with mycosis fungoides

47. 422 Galectin-7 suppresses the erythema and cytokine productions in Nc/Nga mice, an atopic dermatitis model

49. Schwannomatosis presenting with large subcutaneous and retroperitoneal tumours

50. Is Wnt5a overexpression sufficient for generating a psoriasis-like phenotype in transgenic mice?

Catalog

Books, media, physical & digital resources